DCB - Going beyond in-stent restenosis

With the collaboration of Slovenia Society for Cardiology, Working Group for interventional Cardiology and Working Group for Interventional Cardiology, Israel Heart Society

Anchorpersons: M. Bunc, S. Minha

Discussants: J. Fajadet, Y. Feld, M. Cercek

Summary

This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.

Learning Objectives

To understand the role of DCB in special clinical scenarios (e.g., ACS, calcified lesions, bifurcations)
To review the current evidence for DCB-based revascularisation therapy for native coronary lesions
To detail the necessary steps needed to increase the potential for successful DCB-based revascularisation

Presentations available when logged in:

Case 1 - Israel - It’s a STEMI, must we leave metal behind?
How would I treat case 1?
Case 1 - Treatment
Case 2 - Slovenia - Coronary ostial stenosis in a patient with ACS: how should I treat?
How would I treat case 2?
Case 2 - Treatment
Session evaluation and key learnings